70 related articles for article (PubMed ID: 25478998)
1. Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis.
Zhou Z; Guo Y; Liu Y; Zhang F; Wang Y; Shen B; Qin Y; Qiu J
Exp Cell Res; 2015 Feb; 331(2):399-407. PubMed ID: 25478998
[TBL] [Abstract][Full Text] [Related]
2. The scaffolding protein DLG5 promotes glioblastoma growth by controlling Sonic Hedgehog signaling in tumor stem cells.
Kundu S; Nandhu MS; Longo SL; Longo JA; Rai S; Chin LS; Richardson TE; Viapiano MS
Neuro Oncol; 2022 Aug; 24(8):1230-1242. PubMed ID: 34984467
[TBL] [Abstract][Full Text] [Related]
3. Identification of methylated genes associated with aggressive bladder cancer.
Marsit CJ; Houseman EA; Christensen BC; Gagne L; Wrensch MR; Nelson HH; Wiemels J; Zheng S; Wiencke JK; Andrew AS; Schned AR; Karagas MR; Kelsey KT
PLoS One; 2010 Aug; 5(8):e12334. PubMed ID: 20808801
[TBL] [Abstract][Full Text] [Related]
4.
Marquez J; Mann N; Arana K; Deniz E; Ji W; Konstantino M; Mis EK; Deshpande C; Jeffries L; McGlynn J; Hugo H; Widmeier E; Konrad M; Tasic V; Morotti R; Baptista J; Ellard S; Lakhani SA; Hildebrandt F; Khokha MK
J Med Genet; 2021 Jul; 58(7):453-464. PubMed ID: 32631816
[TBL] [Abstract][Full Text] [Related]
5. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells.
Tsai YC; Ho PY; Tzen KY; Tuan TF; Liu WL; Cheng AL; Pu YS; Cheng JC
Mol Cancer Ther; 2015 Mar; 14(3):810-20. PubMed ID: 25589492
[TBL] [Abstract][Full Text] [Related]
7. LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk.
Salas LA; Villanueva CM; Tajuddin SM; Amaral AF; Fernandez AF; Moore LE; Carrato A; Tardón A; Serra C; García-Closas R; Basagaña X; Rothman N; Silverman DT; Cantor KP; Kogevinas M; Real FX; Fraga MF; Malats N
Epigenetics; 2014 Nov; 9(11):1532-9. PubMed ID: 25482586
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.
Li L; Zhang Y; Fan Y; Sun K; Su X; Du Z; Tsao SW; Loh TK; Sun H; Chan AT; Zeng YX; Chan WY; Chan FK; Tao Q
Epigenomics; 2015; 7(2):155-73. PubMed ID: 25479246
[TBL] [Abstract][Full Text] [Related]
9. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
van Kessel KE; Van Neste L; Lurkin I; Zwarthoff EC; Van Criekinge W
J Urol; 2016 Mar; 195(3):601-7. PubMed ID: 26327355
[TBL] [Abstract][Full Text] [Related]
11. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
12. Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.
Aine M; Sjödahl G; Eriksson P; Veerla S; Lindgren D; Ringnér M; Höglund M
Genome Med; 2015; 7(1):23. PubMed ID: 25810763
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.
Li Z; Li D; Zhang G; Xiong J; Jie Z; Cheng H; Cao Y; Jiang M; Lin L; Le Z; Tan S; Zou W; Gong B; Lin S; Yang K
Am J Cancer Res; 2014; 4(6):648-62. PubMed ID: 25520857
[TBL] [Abstract][Full Text] [Related]
14. Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades.
Del Senno L; Maestri I; Piva R; Hanau S; Reggiani A; Romano A; Russo G
J Urol; 1989 Jul; 142(1):146-9. PubMed ID: 2733094
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.
Lambertz I; Kumps C; Claeys S; Lindner S; Beckers A; Janssens E; Carter DR; Cazes A; Cheung BB; De Mariano M; De Bondt A; De Brouwer S; Delattre O; Gibbons J; Janoueix-Lerosey I; Laureys G; Liang C; Marchall GM; Porcu M; Takita J; Trujillo DC; Van Den Wyngaert I; Van Roy N; Van Goethem A; Van Maerken T; Zabrocki P; Cools J; Schulte JH; Vialard J; Speleman F; De Preter K
Clin Cancer Res; 2015 Jul; 21(14):3327-39. PubMed ID: 25805801
[TBL] [Abstract][Full Text] [Related]
16. Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.
Marzese DM; Hoon DS
Expert Rev Mol Diagn; 2015 May; 15(5):647-64. PubMed ID: 25797072
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
[TBL] [Abstract][Full Text] [Related]
18. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
Ren J; Xu Y; Huang Q; Yang J; Yang M; Hu K; Wei K
Anticancer Drugs; 2015 Jun; 26(5):498-507. PubMed ID: 25714087
[TBL] [Abstract][Full Text] [Related]
19. A urine-based methylation signature for risk stratification within low-risk prostate cancer.
Jatkoe TA; Karnes RJ; Freedland SJ; Wang Y; Le A; Baden J
Br J Cancer; 2015 Mar; 112(5):802-8. PubMed ID: 25695483
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
